USPTO serial 99653904
AEQUOVIX
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HOFFMAN, CHRISTOPHER J
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: October 1, 2026
Need help with AEQUOVIX?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Office Action issues
The examiner has identified that you need to clarify the description of goods in Class 5 by specifying the exact diseases or physical conditions your preparations target.
Owner
AEQUOVIX BIO LLC
lafayette, IN, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for the prevention and treatment of diseases and disorders; Pharmaceutical preparations for gene therapy for the treatment of diseases and disorders | ACTIVE | — |
| 042 | Research and development in the pharmaceutical and biotechnology fields; Gene therapy research; Biotechnology research | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jun 15, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jun 14, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 15, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Feb 15, 2026 | NWAP | NEW APPLICATION ENTERED |